IBDEI2OQ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45059,1,3,0)
 ;;=3^Prostate Malignant Neoplasm Screen
 ;;^UTILITY(U,$J,358.3,45059,1,4,0)
 ;;=4^Z12.5
 ;;^UTILITY(U,$J,358.3,45059,2)
 ;;=^5062688
 ;;^UTILITY(U,$J,358.3,45060,0)
 ;;=Z00.00^^200^2237^9
 ;;^UTILITY(U,$J,358.3,45060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45060,1,3,0)
 ;;=3^General Adult Medical Exam w/o Abnormal Findings
 ;;^UTILITY(U,$J,358.3,45060,1,4,0)
 ;;=4^Z00.00
 ;;^UTILITY(U,$J,358.3,45060,2)
 ;;=^5062599
 ;;^UTILITY(U,$J,358.3,45061,0)
 ;;=Z02.79^^200^2237^11
 ;;^UTILITY(U,$J,358.3,45061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45061,1,3,0)
 ;;=3^Medical Certificate Encounter
 ;;^UTILITY(U,$J,358.3,45061,1,4,0)
 ;;=4^Z02.79
 ;;^UTILITY(U,$J,358.3,45061,2)
 ;;=^5062641
 ;;^UTILITY(U,$J,358.3,45062,0)
 ;;=Z71.3^^200^2237^7
 ;;^UTILITY(U,$J,358.3,45062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45062,1,3,0)
 ;;=3^Dietary Counseling
 ;;^UTILITY(U,$J,358.3,45062,1,4,0)
 ;;=4^Z71.3
 ;;^UTILITY(U,$J,358.3,45062,2)
 ;;=^5063245
 ;;^UTILITY(U,$J,358.3,45063,0)
 ;;=Z71.7^^200^2237^10
 ;;^UTILITY(U,$J,358.3,45063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45063,1,3,0)
 ;;=3^HIV Counseling
 ;;^UTILITY(U,$J,358.3,45063,1,4,0)
 ;;=4^Z71.7
 ;;^UTILITY(U,$J,358.3,45063,2)
 ;;=^5063251
 ;;^UTILITY(U,$J,358.3,45064,0)
 ;;=Z71.6^^200^2237^15
 ;;^UTILITY(U,$J,358.3,45064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45064,1,3,0)
 ;;=3^Tobacco Abuse Counseling
 ;;^UTILITY(U,$J,358.3,45064,1,4,0)
 ;;=4^Z71.6
 ;;^UTILITY(U,$J,358.3,45064,2)
 ;;=^5063250
 ;;^UTILITY(U,$J,358.3,45065,0)
 ;;=D86.0^^200^2238^45
 ;;^UTILITY(U,$J,358.3,45065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45065,1,3,0)
 ;;=3^Sarcoidosis of Lung
 ;;^UTILITY(U,$J,358.3,45065,1,4,0)
 ;;=4^D86.0
 ;;^UTILITY(U,$J,358.3,45065,2)
 ;;=^5002442
 ;;^UTILITY(U,$J,358.3,45066,0)
 ;;=D86.1^^200^2238^47
 ;;^UTILITY(U,$J,358.3,45066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45066,1,3,0)
 ;;=3^Sarcoidosis of Lymph nodes
 ;;^UTILITY(U,$J,358.3,45066,1,4,0)
 ;;=4^D86.1
 ;;^UTILITY(U,$J,358.3,45066,2)
 ;;=^5002443
 ;;^UTILITY(U,$J,358.3,45067,0)
 ;;=D86.2^^200^2238^46
 ;;^UTILITY(U,$J,358.3,45067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45067,1,3,0)
 ;;=3^Sarcoidosis of Lung w/ Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,45067,1,4,0)
 ;;=4^D86.2
 ;;^UTILITY(U,$J,358.3,45067,2)
 ;;=^5002444
 ;;^UTILITY(U,$J,358.3,45068,0)
 ;;=D86.89^^200^2238^48
 ;;^UTILITY(U,$J,358.3,45068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45068,1,3,0)
 ;;=3^Sarcoidosis of Other Sites
 ;;^UTILITY(U,$J,358.3,45068,1,4,0)
 ;;=4^D86.89
 ;;^UTILITY(U,$J,358.3,45068,2)
 ;;=^5002453
 ;;^UTILITY(U,$J,358.3,45069,0)
 ;;=D86.9^^200^2238^51
 ;;^UTILITY(U,$J,358.3,45069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45069,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,45069,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,45069,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,45070,0)
 ;;=D86.86^^200^2238^39
 ;;^UTILITY(U,$J,358.3,45070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45070,1,3,0)
 ;;=3^Sarcoid Arthropathy
 ;;^UTILITY(U,$J,358.3,45070,1,4,0)
 ;;=4^D86.86
 ;;^UTILITY(U,$J,358.3,45070,2)
 ;;=^5002451
 ;;^UTILITY(U,$J,358.3,45071,0)
 ;;=D86.87^^200^2238^43
 ;;^UTILITY(U,$J,358.3,45071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45071,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,45071,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,45071,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,45072,0)
 ;;=D86.3^^200^2238^49
 ;;^UTILITY(U,$J,358.3,45072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45072,1,3,0)
 ;;=3^Sarcoidosis of Skin
